ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.16%
      US Tech 100
      17,650.00
      0.05%
      Dow Jones
      39,512.84
      0.32%
      Brent Oil
      82.35
      -0.28%
      Bitcoin
      61,259.53
      0.76%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. 23andMe Holding Company (ME)

      7. 23andMe Holding Company (ME) News

      ME

      23andMe (ME)

      23andMe Holding Company
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ME
      DateTimeSourceHeadlineSymbolCompany
      05/10/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      05/09/20244:50PMGlobeNewswire Inc.23andMe to Report Q4 and Full Year FY2024 Financial ResultsNASDAQ:ME23andMe Holding Company
      04/30/202411:00AMBusiness WirePotter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseNASDAQ:ME23andMe Holding Company
      04/24/20244:05PMGlobeNewswire Inc.23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ME23andMe Holding Company
      04/18/20248:00AMGlobeNewswire Inc.23andMe announces CEO’s intention to pursue a potential take-privateNASDAQ:ME23andMe Holding Company
      04/05/20244:05PMGlobeNewswire Inc.23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
      03/20/20247:30AMGlobeNewswire Inc.23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6NASDAQ:ME23andMe Holding Company
      03/19/20248:00AMGlobeNewswire Inc.23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years AgoNASDAQ:ME23andMe Holding Company
      03/06/20247:30AMGlobeNewswire Inc.23andMe Launches New Genetic Reports on Common Forms of CancerNASDAQ:ME23andMe Holding Company
      03/05/20244:30PMGlobeNewswire Inc.23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
      02/21/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
      02/07/20244:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
      02/07/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      02/07/20244:01PMGlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
      02/06/20247:00AMBusiness WireMoneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.NASDAQ:ME23andMe Holding Company
      01/31/20247:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      01/30/202410:12PMGlobeNewswire Inc.23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernayNASDAQ:ME23andMe Holding Company
      01/30/20245:00PMBusiness WireNighthawk Gold Obtains Final Court Order for the Proposed ArrangementNASDAQ:ME23andMe Holding Company
      01/24/20244:05PMGlobeNewswire Inc.23andMe to Report FY2024 Third Quarter Financial ResultsNASDAQ:ME23andMe Holding Company
      01/22/20248:00AMBusiness WireMoneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo BoardNASDAQ:ME23andMe Holding Company
      01/08/20247:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      12/19/20238:00AMGlobeNewswire Inc.23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohortsNASDAQ:ME23andMe Holding Company
      12/01/20234:06PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ME23andMe Holding Company
      11/28/20237:15AMBusiness WireNighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development CompanyNASDAQ:ME23andMe Holding Company
      11/21/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
      11/21/20234:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
      11/13/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      11/08/20234:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
      11/08/20234:05PMGlobeNewswire Inc.23andMe Reports Second Quarter Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
      11/07/20238:00AMGlobeNewswire Inc.23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health MembershipNASDAQ:ME23andMe Holding Company
       Showing the most relevant articles for your search:NASDAQ:ME

      Your Recent History

      BIT
      P200W5
      NLBNPIT200W5 20991231 52...
      Delayed Upgrade Clock